The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.8M data for 1.2M Compounds and 9.2K Targets. Of those, 1,346K data for 622K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

110 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Pyrimidine-Based Inhibitors of Dynamin I GTPase Activity: Competitive Inhibition at the Pleckstrin Homology Domain.EBI
The University Of Newcastle
Assessment of the in vivo and in vitro opioid activity of bridged hexahydroaporphine and isoquinoline molecules.EBI
Creighton University
Synthesis and pharmacological evaluation of 4,4-disubstituted piperidines.EBI
Anaquest Pharmaceuticals
Synthesis and biological evaluation of 14-alkoxymorphinans. 2. (-)-N-(cyclopropylmethyl)-4,14-dimethoxymorphinan-6-one, a selective mu opioid receptor antagonist.EBI
University Of Innsbruck
X-ray crystal structure of the opioid ligand naltrexonazine.EBI
TBA
Probes for narcotic receptor mediated phenomena. 12. cis-(+)-3-Methylfentanyl isothiocyanate, a potent site-directed acylating agent for delta opioid receptors. Synthesis, absolute configuration, and receptor enantioselectivity.EBI
TBA
Probes for narcotic receptor mediated phenomena. 9. Synthesis of (+/-)-(3 alpha,6a alpha,11a beta)-1,3,4,5,6,11a-hexahydro-2-methyl-2H-3,6a- methanobenzofuro[2,3-c]azocin-10-ol, an oxide-bridged 5-(m-hydroxyphenyl)morphan.EBI
TBA
Probes for narcotic receptor mediated phenomena. 13. Potential irreversible narcotic antagonist-based ligands derived from 6,14-endo-ethenotetrahydronororipavine with 7-(methoxyfumaroyl)amino, (bromoacetyl)amino, or isothiocyanate electrophiles: chemistry, biochemistry, and pharmacology.EBI
TBA
3,7-Diazabicyclane: a new narcotic analgesic.EBI
TBA
Irreversible blockage of opioid receptor types by ester homologues of beta-funaltrexamine.EBI
TBA
Acylmorphinans. A novel class of potent analgesic agents.EBI
TBA
Opioid agonists and antagonists. 6-Desoxy-6-substituted lactone, epoxide, and glycidate ester derivatives of naltrexone and oxymorphone.EBI
TBA
Novel nonnarcotic analgesics with an improved therapeutic ratio. Structure-activity relationships of 8-(methylthio)- and 8-(acylthio)-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines.EBI
TBA
Synthesis and biological evaluation of 14-alkoxymorphinans. 1. Highly potent opioid agonists in the series of (-)-14-methoxy-N-methylmorphinan-6-ones.EBI
TBA
14 beta-(2-bromoacetamido)morphine and 14 beta-(2-bromoacetamido)morphinone.EBI
TBA
Synthesis and pharmacological studies of 4,4-disubstituted piperidines: a new class of compounds with potent analgesic properties.EBI
TBA
Potential affinity labels for the opiate receptor based on fentanyl and related compounds.EBI
TBA
Common anionic receptor site hypothesis: its relevance to the antagonist action of naloxone.EBI
TBA
Synthesis of analogues of acetylmethadol and methadol as potential narcotic antagonists.EBI
TBA
Opiate receptor interaction of compounds derived from or structurally related to fentanyl.EBI
TBA
Preparation and analgesic properties of amino acid derivatives of (-)-5,9 alpha-diethyl-2'-hydroxybenzomorphan.EBI
TBA
Synthesis and analgesic activity of some 5-(4-hydroxyphenyl)-2-azabicyclo[3.2.1]octanes.EBI
TBA
Some spiro analogues of the potent analgesic ketobemidone.EBI
TBA
Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.EBI
Jagiellonian University Medical College
Multitarget opioid ligands in pain relief: New players in an old game.EBI
University Of Catania
Structure-Activity Relationships of the Peptide Kappa Opioid Receptor Antagonist Zyklophin.EBI
The University Of Kansas
Potency enhancement of theż-opioid receptor antagonist probe ML140 through sulfonamide constraint utilizing a tetrahydroisoquinoline motif.EBI
University Of Kansas Specialized Chemistry Center
Novel fluoroalkyl derivatives of selective kappa opioid receptor antagonist JDTic: Design, synthesis, pharmacology and molecular modeling studies.EBI
Universit£
Novel cyclic biphalin analogue with improved antinociceptive properties.EBI
Universit£
Development of¿ opioid receptor antagonists.EBI
Research Triangle Institute
Deconstructing 14-phenylpropyloxymetopon: minimal requirements for binding to mu opioid receptors.EBI
University Of Maryland
Ligand binding to nucleic acids and proteins: Does selectivity increase with strength?EBI
Universit£T Des Saarlandes
Toward a structure-based model of salvinorin A recognition of the kappa-opioid receptor.EBI
University Of Minnesota
Effect of a 6-cyano substituent in 14-oxygenated N-methylmorphinans on opioid receptor binding and antinociceptive potency.EBI
University Of Innsbruck
Synthesis and biological evaluation of 14-alkoxymorphinans. 20. 14-phenylpropoxymetopon: an extremely powerful analgesic.EBI
University Of Innsbruck
Factors influencing agonist potency and selectivity for the opioid delta receptor are revealed in structure-activity relationship studies of the 4-[(N-substituted-4-piperidinyl)arylamino]-N,N-diethylbenzamides.EBI
Research Triangle Institute
Investigation of the selectivity of oxymorphone- and naltrexone-derived ligands via site-directed mutagenesis of opioid receptors: exploring the"address" recognition locus.EBI
University Of Minnesota
Transformation of a kappa-opioid receptor antagonist to a kappa-agonist by transfer of a guanidinium group from the 5'- to 6'-position of naltrindole.EBI
University Of Minnesota
Isosteric replacement of acidic with neutral residues in extracellular loop-2 of the kappa-opioid receptor does not affect dynorphin A(1-13) affinity and function.EBI
University Of Minnesota
Modeling of kappa-opioid receptor/agonists interactions using pharmacophore-based and docking simulations.EBI
Universit£
Mutational evidence for a common kappa antagonist binding pocket in the wild-type kappa and mutant mu[K303E] opioid receptors.EBI
University Of Minnesota
Modified ibogaine fragments: synthesis and preliminary pharmacological characterization of 3-ethyl-5-phenyl-1,2,3,4,5, 6-hexahydroazepino[4,5-b]benzothiophenes.EBI
University Of Minnesota
3-Alkyl ethers of clocinnamox: delayed long-term mu-antagonists with variable mu efficacy.EBI
University Of Bristol
Photoactivatable opiate derivatives as irreversible probes of the mu-opioid receptor.EBI
Universit£
Cyclic enkephalin analogues containing alpha-amino-beta-mercapto-beta,beta-pentamethylenepropionic acid at positions 2 or 5.EBI
Smith Kline And French Laboratories
Combined analgesic/neuroleptic activity in N-butyrophenone prodine-like compounds.EBI
Istituto Superiore Di Sanit£
N-substituent modulation of opiate agonist/antagonist activity in resolved 3-methyl-3-(m-hydroxyphenyl)piperidines.EBI
TBA
ORL1 receptor ligands: structure-activity relationships of 8-cycloalkyl-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-ones.EBI
F. Hoffmann-La Roche
N-Cyclohexylethyl-N-noroxymorphindole: a mu-opioid preferring analogue of naltrindole.EBI
University Of Maryland
Syntheses of potent Leu-enkephalin analogs possessing beta-hydroxy-alpha,alpha-disubstituted-alpha-amino acid and their characterization to opioid receptors.EBI
Institute For Bioorganic Research
 
Synthesis and biological evaluation of 14-alkoxymorphinans. 14.1 14-ethoxy-5-methyl substituted indolomorphinans with opioid receptor selectivityEBI
TBA
Synthesis and activity of endomorphin-2 and morphiceptin analogues with proline surrogates in position 2.EBI
Sapienza University Of Rome
A new group of oxime carbamates as reversible inhibitors of fatty acid amide hydrolase.EBI
Università
Synthesis and evaluation of opioid receptor-binding affinity of elaeocarpenine and its analogs.EBI
Kyorin Pharmaceutical
Novel delta opioid receptor agonists exhibit differential stimulation of signaling pathways.EBI
University Of Medicine And Dentistry Of New Jersey-Robert Wood Johnson Medical School And The Informatics Institute Of Umdnj
The effects of C-terminal modifications on the opioid activity of [N-benzylTyr(1)]dynorphin A-(1-11) analogues.EBI
University Of Kansas
Design, synthesis, and pharmacological activities of dynorphin A analogues cyclized by ring-closing metathesis.EBI
The University Of Kansas
 
trans N-Methyl-N-[2-(1-pyrrolidinyl)cyclohexyl] cycloprop-2-ene-1-carboxamides: Novel lipophilic kappa opioid agonistsEBI
TBA
 
Stereoselective synthesis and evaluation of all stereoisomers of Z4349, a novel and selective μ-opioid analgesicEBI
TBA
Convenient synthesis and in vitro pharmacological activity of 2-thioanalogs of salvinorins A and B.EBI
University Of Mississippi
Studies toward the pharmacophore of salvinorin A, a potent kappa opioid receptor agonist.EBI
The University Of Melbourne
Synthesis and biological evaluation of 14-alkoxymorphinans. 21. Novel 4-alkoxy and 14-phenylpropoxy derivatives of the mu opioid receptor antagonist cyprodime.EBI
University Of Innsbruck
Structure-activity study on the Phe side chain arrangement of endomorphins using conformationally constrained analogues.EBI
Biological Research Center Of The Hungarian Academy Of Sciences
Synthesis and opioid activity of side-chain-to-side-chain cyclic dynorphin A-(1-11) amide analogues cyclized between positions 2 and 5. 1. Substitutions in position 3.EBI
University Of Maryland
Effects of the substitution of Phe4 in the opioid peptide [D-Ala8]dynorphin A-(1-11)NH2.EBI
University Of Maryland
Mechanism of action of the diazabicyclononanone-type kappa-agonists.EBI
UniversitäT WüRzburg
Opioid activity of 4-imidazolidinone positional analogues of Leu-Enkephalin.EBI
Institute For Molecular Studies
3-Pyrroline containing arylacetamides: a novel series of remarkably selective kappa-agonists.EBI
Chinese Academy Of Sciences
Benzimidazolone-based selective ?EBI
University Of Florida
Potent and selective indolomorphinan antagonists of the kappa-opioid receptor.EBI
University Of Minnesota
An LP1 analogue, selective MOR agonist with a peculiar pharmacological profile, used to scrutiny the ligand binding domain.EBI
University Of Catania
Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure-Functional Selectivity Relationships (SFSRs) and Therapeutic Potential.EBI
Shanghaitech University
Discovery of Benzamidine- and 1-Aminoisoquinoline-Based Human MAS-Related G-Protein-Coupled Receptor X1 (MRGPRX1) Agonists.EBI
Eisai
Conformationally constrained deltorphin analogs with 2-aminotetralin-2-carboxylic acid in position 3.EBI
Hungarian Academy Of Sciences
Chemistry, binding affinities, and behavioral properties of a new class of"antineophobic" mitochondrial DBI receptor complex (mDRC) ligands.EBI
Mayo Foundation
Analgesics. 1. Synthesis and analgesic properties of N-sec-alkyl- and N-tert-alkylnormorphines.EBI
TBA
Conformation of 2,9-dimethyl-3'-hydroxy-5-phenyl-6,7-genzomorphan and its relation to other analgetics and enkephalin.EBI
TBA
Studies in the (+)-morphinan series. 5. Synthesis and biological properties of (+)-naloxone.EBI
TBA
Quantum chemical studies of N-substituent variation in the oxymorphone series of opiate narcotics.EBI
TBA
Paradoxical effects of N-cyanoalkyl substituents upon the activities of several classes of opioids.EBI
TBA
Deoxymorphines: role of the phenolic hydroxyl in antinociception and opiate receptor interactions.EBI
TBA
N-(2-Cyanoethyl) derivatives of meperidine, ketobemidone, and a potent 6,7-benzomorphan.EBI
TBA
Development of high-affinity 5-HT3 receptor antagonists. Structure-affinity relationships of novel 1,7-annelated indole derivatives.EBI
Solvay Duphar
Enkephalin analogs as systemically active antinociceptive agents: O- and N-alkylated derivatives of the dipeptide amide L-2,6-dimethyltyrosyl-N-(3-phenylpropyl)-D-alaninamide.EBI
Searle
Synthesis and pharmacological characterization of (+/-)-5,9 alpha-dimethyl-2-[2-(4-fluorophenyl)ethyl]-2'-hydroxy-6,7-benzomorphan (fluorophen), a ligand suitable for visualization of opiate receptors in vivo.EBI
TBA
In vitro labeling of serotonin-S2 receptors: synthesis and binding characteristics of [3H]-7-aminoketanserin.EBI
TBA
Design, synthesis, and opioid activity of arodyn analogs cyclized by ring-closing metathesis involving Tyr(allyl).EBI
University Of Kansas
Cholecystokinin-A receptor ligands based on the kappa-opioid agonist tifluadom.EBI
Merck Sharp & Dohme Research Laboratories
Modulation of opioid receptor affinity and efficacy via N-substitution of 9?-hydroxy-5-(3-hydroxyphenyl)morphan: Synthesis and computer simulation study.EBI
National Institute On Drug Abuse And The National Institute On Alcohol Abuse
Preparation and opioid activity of analogues of the analgesic dipeptide 2,6-dimethyl-L-tyrosyl-N-(3-phenylpropyl)-D-alaninamide.EBI
G.D. Searle And
Novel indolodioxanes with antihypertensive effects: potent ligands for the 5-HT1A receptor.EBI
Upjohn
Inhibitor Discovery for the Human GLUT1 from Homology Modeling and Virtual Screening.BDB
Icahn School Of Medicine At Mount Sinai
Novel 4-heteroaryl-antipyrines as DPP-IV inhibitors.BDB
Cairo University
Characterisation of melanocortin receptor subtypes by radioligand binding analysis.BDB
Uppsala